ACCD - Accolade, Inc.

QQQ $ 479.98 $ -2.50 (-0.52 %)

DIA $ 391.11 $ -0.43 (-0.11 %)

SPY $ 544.70 $ -2.15 (-0.39 %)

TLT $ 91.77 $ -1.74 (-1.86 %)

GLD $ 215.03 $ 0.02 (0.01 %)

Previous Close

$ 3.58

Open

$ 4.34

Bid

$ 3.59 x 100

Ask

$ 0.00 x 0

Day's Range

$ 3.53 - $ 4.34

52 Week Range

$ 3.52 - $ 15.36

Volume

18,085,921

Average Volume

Market Cap

279.67M

Beta (5Y Monthly)

$ 2.10

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	06-27-2024	05-31-2024	10-Q
2	04-25-2024	02-29-2024	10-K
3	01-08-2024	11-30-2023	10-Q
4	10-04-2023	08-31-2023	10-Q
5	06-29-2023	05-31-2023	10-Q
6	04-28-2023	02-28-2023	10-K
7	01-09-2023	11-30-2022	10-Q
8	10-06-2022	08-31-2022	10-Q
9	07-01-2022	05-31-2022	10-Q
10	05-02-2022	02-28-2022	10-K
11	01-11-2022	11-30-2021	10-Q
12	10-07-2021	08-31-2021	10-Q
13	07-08-2021	05-31-2021	10-Q
14	05-07-2021	02-28-2021	10-K
15	01-07-2021	11-30-2020	10-Q
16	10-14-2020	08-31-2020	10-Q
17	08-13-2020	05-31-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Guggenheim Maintains Buy on Accolade, Lowe...
06/28/2024 17:03:25

Guggenheim analyst Sandy Draper maintains Accolade (NASDAQ:ACCD) with a Buy and lowers the price target from $13 to $6.

Stifel Maintains Buy on Accolade, Lowers P...
06/28/2024 16:56:14

Stifel analyst David Grossman maintains Accolade (NASDAQ:ACCD) with a Buy and lowers the price target from $13 to $8.

Truist Securities Maintains Buy on Accolad...
06/28/2024 16:01:23

Truist Securities analyst Jailendra Singh maintains Accolade (NASDAQ:ACCD) with a Buy and lowers the price target from $14 t...

Morgan Stanley Maintains Equal-Weight on A...
06/28/2024 15:51:24

Morgan Stanley analyst Ricky Goldwasser maintains Accolade (NASDAQ:ACCD) with a Equal-Weight and lowers the price target fro...

Barclays Maintains Equal-Weight on Accolad...
06/28/2024 15:38:30

Barclays analyst Stephanie Davis maintains Accolade (NASDAQ:ACCD) with a Equal-Weight and lowers the price target from $11 t...

apple-to-rally-around-17-here-are-10-top-analyst-forecasts-for-friday

Apple To Rally Around 17%? Here Are 10 Top...
06/28/2024 13:33:07

nike-accolade-and-other-big-stocks-moving-lower-in-fridays-pre-market-session

Nike, Accolade And Other Big Stocks Moving...
06/28/2024 13:08:43

Canaccord Genuity Maintains Buy on Accolad...
06/28/2024 12:38:29

Canaccord Genuity analyst Richard Close maintains Accolade (NASDAQ:ACCD) with a Buy and lowers the price target from $16 to ...

Needham Maintains Buy on Accolade, Lowers ...
06/28/2024 10:20:46

Needham analyst Ryan MacDonald maintains Accolade (NASDAQ:ACCD) with a Buy and lowers the price target from $13 to $8.

accolade-stock-tumbles-on-q1-earnings-weak-guidance-what-you-need-to-know

Accolade Stock Tumbles On Q1 Earnings, Wea...
06/27/2024 20:34:30

Accolade Inc shares are tanking in Thursday's after-hours session after the company reported financial results for its fisc...

Accolade Sees Q2 Revenue $104M-$106M Vs $1...
06/27/2024 20:06:13

Financial OutlookAccolade provides forward-looking guidance on revenue and Adjusted EBITDA, a non-GAAP financial measure.For th...

Accolade Q1 EPS $(0.35) Beats $(0.48) Esti...
06/27/2024 20:04:26

Accolade (NASDAQ:ACCD) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.48) by 2...

Needham Reiterates Buy on Accolade, Mainta...
06/24/2024 17:22:26

Needham analyst Ryan MacDonald reiterates Accolade (NASDAQ:ACCD) with a Buy and maintains $13 price target.

Guggenheim Maintains Buy on Accolade, Lowe...
05/08/2024 17:25:12

Guggenheim analyst Sandy Draper maintains Accolade (NASDAQ:ACCD) with a Buy and lowers the price target from $17 to $13.

Wells Fargo Maintains Equal-Weight on Acco...
04/30/2024 14:50:00

Wells Fargo analyst Stan Berenshteyn maintains Accolade (NASDAQ:ACCD) with a Equal-Weight and lowers the price target from $...

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
04/26/2024 20:31:15

Why Aon Shares Are Trading Lower By Around...
04/26/2024 17:56:57

Morgan Stanley Maintains Equal-Weight on A...
04/26/2024 16:33:21

Morgan Stanley analyst Ricky Goldwasser maintains Accolade (NASDAQ:ACCD) with a Equal-Weight and lowers the price target fro...

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
04/26/2024 16:31:22

Truist Securities Maintains Buy on Accolad...
04/26/2024 15:37:28

Truist Securities analyst Jailendra Singh maintains Accolade (NASDAQ:ACCD) with a Buy and lowers the price target from $16 t...

CLASS ACTION DEADLINES - JOIN NOW!

07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)

07/01/2024 Equinix, Inc. (EQIX)

07/02/2024 Intel Corporation (INTC)

07/05/2024 AXT, Inc. (AXTI)

07/05/2024 Altimmune, Inc. (ALT)

07/09/2024 Li Auto Inc. (LI)

07/12/2024 Inari Medical, Inc. (NARI)

07/12/2024 Sprout Social, Inc. (SPT)

07/15/2024 UnitedHealth Group Inc. (UNH)

07/16/2024 Teladoc Health, Inc. (TDOC)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)

ACCDAccolade, Inc.

Nasdaq accolade.com

$ 3.60 $ -2.81 (-43.97 %)

Friday, 28-Jun-2024 15:59:53 EDT